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Computerised therapy for depression with
clinician vs. assistant and brief vs. extended
phone support: study protocol for a randomised
controlled trial
Lina Gega1*, Louise Swift1, Garry Barton1, Gillian Todd1,2, Nesta Reeve2, Kelly Bird2, Richard Holland1,
Amanda Howe1,3, Jon Wilson2 and Jo Molle1,2
Abstract
Background: Computerised cognitive behaviour therapy (cCBT) involves standardised, automated, interactive self-help
programmes delivered via a computer. Randomised controlled trials (RCTs) and observational studies have shown than
cCBT reduces depressive symptoms as much as face-to-face therapy and more than waiting lists or treatment as usual.
cCBT’s efficacy and acceptability may be influenced by the “human” support offered as an adjunct to it, which can vary
in duration and can be offered by people with different levels of training and expertise.
Methods/design: This is a two-by-two factorial RCT investigating the effectiveness, cost-effectiveness and acceptability
of cCBT supplemented with 12 weekly phone support sessions are either brief (5–10 min) or extended (20–30 min) and
are offered by either an expert clinician or an assistant with no clinical training. Adults with non-suicidal depression in
primary care can self-refer into the study by completing and posting to the research team a standardised
questionnaire. Following an assessment interview, eligible referrals have access to an 8-session cCBT programme called
Beating the Blues and are randomised to one of four types of support: brief-assistant, extended-assistant, brief-clinician
or extended-clinician.
A sample size of 35 per group (total 140) is sufficient to detect a moderate effect size with 90% power on our primary
outcome measure (Work and Social Adjustment Scale); assuming a 30% attrition rate, 200 patients will be randomised.
Secondary outcome measures include the Beck Depression and Anxiety Inventories and the PHQ-9 and GAD-7. Data
on clinical outcomes, treatment usage and patient experiences are collected in three ways: by post via self-report
questionnaires at week 0 (randomisation) and at weeks 12 and 24 post-randomisation; electronically by the cCBT
system every time patients log-in; by phone during assessments, support sessions and exit interviews.
Discussion: The study’s factorial design increases its efficiency by allowing the concurrent investigation of two types of
adjunct support for cCBT with a single sample of participants. Difficulties in recruitment, uptake and retention of
participants are anticipated because of the nature of the targeted clinical problem (depression impairs motivation) and
of the studied interventions (lack of face-to-face contact because referrals, assessments, interventions and data
collection are completed by phone, computer or post).
Trial registration: Current Controlled Trials ISRCTN98677176
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Background
Depression is one of the most prevalent and burdensome
health and social problems world-wide [1]. Access to
evidence-based psychological interventions, especially
cognitive behaviour therapy (CBT), is restricted because of
scarce healthcare resources and too few trained therapists
[2]. Computerised cognitive behaviour therapy (cCBT) can
be used as an alternative, or as a primer, to traditional
face-to-face CBT for mild-to-moderate depression within
a stepped care model [3].
A recent meta-review [4] supported the efficacy of
cCBT for depression, drawing on ten systematic reviews
and numerous randomised controlled trials (RCTs) that
had demonstrated that cCBT for depression can be more
effective than treatment as usual [5,6] or than a waiting
list control [7,8], and as effective as therapist-delivered
face-to-face CBT [9,10]. cCBT is generally an acceptable
intervention to patients [11,12]; however, its uptake is
low and the drop-out rate can be high [13-15]. This is
common for e-health interventions [16] and more so for
open access websites and observational studies rather
than for controlled trials [17,18].
The efficacy and acceptability of cCBT may be influ-
enced by whether, and how much, human support is
offered as an adjunct to it. A meta-analysis [19,20] found
that Internet- delivered CBT was four times more effective
when delivered with a supportive online therapist contact.
Two further meta-analyses [10,20] indicated that the
longer the therapist input, the better the clinical outcomes
with cCBT. A recently published RCT [7] found margin-
ally better outcomes for depression with cCBT supple-
mented by weekly email therapist support compared to
unguided cCBT. Two other RCTs on social phobia found
that cCBT with therapist guidance by email was superior
to unguided cCBT [21] and an Internet-accessed CBT
self-help manual had better outcomes when supplemented
by an online discussion group [22]. Also, users of a self-
help book for bulimia, albeit not computerised, improved
more if they had some personalised guidance rather than
none [23,24].
The relationship between adjunct support and improved
adherence or outcomes with cCBT is not always supported
in the literature. Having three face-to-face support sessions
with a therapist as an adjunct to cCBT for bulimia nervosa
did not enhance adherence or outcomes compared to
cCBT with minimal guidance [25]. Also, weekly telephone
tracking for cCBT for depression did not have an advantage
over standalone cCBT [26]. Finally, more frequent therapist
contact via email (three times vs. once per week) did not
improve outcomes and adherence with cCBT for panic
[27]. There is a need for further research to investigate
whether keeping support sessions for cCBT for depression
as brief as possible can save staff time without significantly
compromising outcomes and acceptability, or whether
offering longer support sessions can yield greater patient
improvement or better completion rates.
Some cCBT studies [21] use therapists who, whilst more
expensive, may satisfy patients’ expectations and needs bet-
ter than non-experts. Other studies use less experienced
support staff, such as an administrator [28,29], lay
counsellors [26] or psychology students [22], who are
easier to find and less costly to employ, but may be less
effective or less acceptable, or may have hidden costs
(for example, increased patient use of other services).
Two studies [28,29] directly compared cCBT with
phone or email support from a therapist vs. an assistant
and found similar symptom improvement in people
with depression and generalized anxiety disorder (GAD)
between the two groups. No studies have so far investi-
gated the cost-effectiveness or explored patients’ experi-
ences of receiving therapist vs. assistant support as an
adjunct to cCBT.
This paper describes the protocol for a factorial RCT
whose primary aim is to compare the clinical effectiveness,
cost-effectiveness and acceptability of cCBT with two dif-
ferent types of support offered as an adjunct to it: brief vs.
extended, and clinician vs. assistant support. To this end
the study has the following primary objectives:
1. To compare clinical outcomes (depression and
anxiety symptoms, functioning and quality of life)
between brief and extended support for cCBT and
between clinician and assistant support for cCBT.
2. To assess the cost-effectiveness of cCBT with brief
vs. extended support and with clinician vs. assistant
support and to estimate the cost for the National
Health Service (NHS} of the population-wide
implementation of the most cost-effective option.
3. To report and compare acceptability of cCBT
(attrition, treatment usage and patient experiences)
between brief vs. extended support and between
clinician vs. assistant support.
The study also aims to evaluate the process of
recruiting and screening patients with depression for
cCBT, to explore effect modifiers (specifically severe
vs. mild/moderate depression or anxiety, and referrals
from general practitioners (GPs) vs. mental health pro-
fessionals) and predictors of cCBT usage and out-
comes, to indicate the most appropriate measures for
assessing clinical outcomes with cCBT, and to compare
the computer and the support person with respect to
creating and maintaining a therapeutic alliance with
the patient. To this end, the study has the following
secondary objectives:
1. To compare the characteristics of referrals for cCBT
who take up the offer for assessment and treatment
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with the characteristics of referrals who drop out
before randomisation (refusals).
2. To assess whether a clinician or an assistant can
reliably predict patient suitability for cCBT by
reviewing patients’ written responses to a
standardised questionnaire.
3. To explore whether outcomes and satisfaction with
different levels of support for cCBT vary for certain
sub-groups of patients (severe vs. mild/moderate
depression or anxiety and referrals from GPs vs.
mental health professionals).
4. To investigate whether patient characteristics and
treatment group predicts clinical outcomes, number
of cCBT sessions completed, and patient satisfaction.
5. To assess the similarity of various standardised self-
report questionnaires for the assessment of
depression, anxiety and functioning and quality of
life.
6. To compare and assess the similarity of alliance
ratings and explore patients’ experiences using a
computerised self-help system vs. speaking to a
support person on the telephone.
7. To identify common themes and key differences in
the content and style of brief vs. extended support
and of clinician vs. assistant support.
Methods/design
Design
This is a two-by-two factorial RCT. Patients are randomly
allocated to an eight-session cCBT programme supported
either by a clinician or by an assistant, each offering either
brief or extended phone support. The four randomly-
created groups are: brief-clinician, brief-assistant, extended-
clinician or extended-assistant support for cCBT. The pri-
mary follow-up point is at 3 months post-randomisation
and the secondary follow-up point is at 6 months post-
randomisation.
Sample
Patients are eligible for the trial if: their primary problem
is non-suicidal, non-psychotic, unipolar mood disorder,
such as depression or dysthymia or mixed anxiety and de-
pressive disorder based on ICD-10 criteria [30]; they sign
a written consent form for screening and for treatment;
they are registered with a GP within the local area and
they are at least 18 years old. There is no upper cut-off for
severity of depression or anxiety symptoms and partici-
pants can have comorbid physical and mental health pro-
blems and receive concurrent treatments. Referrals are
only excluded if they have: high current risk of suicide
(current suicide plans and intent to kill themselves);
current psychotic symptoms (due to schizophrenia or bi-
polar affective disorder or severe depression with psych-
otic features); current substance abuse/misuse (severe
dependency on alcohol, illicit drugs or tranquilisers) or
cognitive impairment that impedes the use of a computer.
Recruitment
Health professionals working in primary care, or in the vol-
untary sector, signpost patients to the study by handing
them an envelope containing a patient information sheet, a
consent form and a self-referral questionnaire. People who
find out about the study through public advertisement can
also contact the research team directly by telephone or
email, or can download the study entry documents from a
designated website. Patients are encouraged to email or
telephone the research team before completing and posting
the self-referral questionnaire and consent form, should
they have any questions or if they wish to discuss some-
thing confidential.
Assessment
On receiving a completed self-referral questionnaire and
consent form, the study’s research associate (JM) assigns a
unique trial identifier number to the patient and copies
their self-referral questionnaire twice after masking any
identifiable patient details. The anonymised copies of the
self-referral questionnaire are distributed to the study’s as-
sistant (KB) and to two expert clinicians (NR, GT). They all
independently read the self-referral questionnaire, and rec-
ord their judgment on the patient’s diagnosis and suitability
for cCBT. The research associate (JM) invites the patient
for a brief (15 to 30 minutes) telephone interview to deter-
mine their eligibility for study entry and to discuss any
questions they may have about the study. If a patient is not
eligible, the research associate (JM) discusses this with
them, suggests alternative avenues for help, and records the
reasons for ineligibility in a web-based database.
Treatment allocation
Patients eligible for trial entry receive a treatment con-
sent form and a set of blank standardised self-report
questionnaires (baseline assessments) to complete and
post to the research team in a stamped addressed enve-
lope. On receiving the completed treatment consent
form and baseline assessments, the research associate
(JM) randomises patients into one of the four study
intervention groups using a web-based system set up by
the Clinical Research Trials Unit (CRTU) of the Norfolk
& Norwich University Hospitals (NNUH) Trust. The
system follows a block-randomisation: for every 32 refer-
rals, it ensures that eight patients are assigned to each of
the four arms of the trial so that the clinician and assist-
ant who offer phone support to patients have similar
workload distribution over time. Figure 1 is a CON-
SORT diagram [31] of the randomisation and flow of
participants through the study.
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Interventions
After randomisation, the research associate (JM) emails
or telephones the patient with an access code for logging
into the cCBT system and with the details of the person
who will be supporting them. Patients are registered
with the system as active participants once they log in
for the first time and choose their own password. The
support person emails or telephones the patient within a
week of randomiation to introduce themselves and
schedule their support sessions. All patients are offered
an intervention with two components, cCBT and some
type of adjunct telephone support.
cCBT
The computerised cCBT system used in this study is
Beating the Blues (BtB) marketed by Ultrasis Ltd based
in London, UK.. This was chosen because at the time of
the study set-up it was the cCBT system recommended
in the UK by the National Institute for Clinical Excel-
lence (NICE) [3] and the Department of Health (DH)
[32] as an effective and cost-effective treatment method
for mild-moderate depression in primary care. During
eight 50-minute sessions, BtB uses text, videos, voice
instructions, diagrams and pictures to teach patients
how to identify unhelpful thoughts and come up with
helpful alternatives, and how to perform activity sched-
uling, problem-solving and other relevant homework
tasks between their computer sessions. Each computer
session builds on the one before and its completion trig-
gers printing of a progress report.
Most patients use the computerised therapy system
from home; those who do not have access to a computer,
or who wish to use the system outside their home envir-
onment, can access the cCBT system in public places
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- Received allocated intervention 
(completed > 5 cCBT sessions) 
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Brief-Clinician Support 
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Figure 1 CONSORT* diagram of participant flow (*according to Schulz KF, AltmanDG, Moher D, the CONSORT Group, 2010).
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such as libraries, community centres or Internet cafes
and are reimbursed for their expenses. Patients go
through BtB at their own pace, but it is suggested that
they cover a module per week, allowing enough time in-
between sessions for homework (for example, rehearsing
practical tasks or keeping diaries), with the aim of com-
pleting the whole programme within 12 weeks.
Telephone support
Individual support is given as a scheduled, telephone call
on average once a week or fortnight (depending on how
fast the patient goes through the programme) for 3
months or longer, and up to 6 months if needed. Sup-
port sessions are either brief (5 to 10 minutes per call)
or extended (20 to 30 minutes per call). Patients can re-
ceive up to 12 telephone calls over 12 to 24 weeks, so
they have a maximum of 1 to 2 hrs of brief support or 4
to 6 hrs of extended support throughout using the cCBT
system. Ad-hoc contact is also available, in case patients
raise risk issues or get stuck with the system.
Both brief and extended support sessions focus on
monitoring patient progress and mental state as neces-
sary. Extended support sessions offer additional therapy
advice by elaborating on some of the treatment techni-
ques described in the cCBT system (for example, to help
patients identify thinking errors and alternative beliefs,
problem-solving difficulties with doing homework,
etcetera). Support is not standardised, so that it can be
tailored to individual patients’ needs and preferences.
Support sessions are offered either by a clinician (JT), a
PhD nurse with CBT clinical qualifications and 20 years
clinical experience, or by an assistant (KB), a graduate
psychologist with no clinical qualifications but with 2 years
experience of working with people with depression and
anxiety in a voluntary organisation. Both members of staff
receive individual telephone or face-to-face clinical supervi-
sion from a senior CBT-trained Clinical Psychologist (NR)
and research supervision from the Chief Investigator (LG).
Data collection
Baseline demographic and clinical characteristics are
obtained by the self-referral questionnaire which is com-
pleted by patients and posted to the research team be-
fore randomization. The self-referral questionnaire has
been suitably adapted for the purpose of this study from
its previous validated version [33]. The questionnaire
has nine sections which elicit quantitative and narrative
data about patients’ symptoms, computer literacy, life-
style, past and present treatments including medication,
and therapy goals and preferences for therapist-delivered
interventions vs. computerised self-help.
Data on clinical outcomes, resource use and patient
experiences are collected in two ways: both by post and
electronically. Postal questionnaires are sent to patients at
baseline (randomization) and then at weeks 12 (primary
end-point) and 24 (follow-up) post-randomization with
instructions to complete them and return to the research
team. Electronic data are collected automatically by the
cCBT system during each cCBT session. The timing of
electronic data collection is recorded by the cCBT system
but it varies according to the frequency with which
patients log into it.
Narrative data are also collected during a 15 to 30 mi-
nute assessment with the patient pre-randomization, as
part of support sessions by the clinician and the assist-
ant, and during a 15 minute telephone interview, which
asks about patient views and experiences of using a
computerised self-help system and of having telephone
support at 12-weeks post-randomization, by the study’s
research associate (JM).
Below we give a detailed description of individual data
collection tools and justification for their inclusion in
the study. All standardised measures are self-reported
and are collected independently of the staff proving tele-
phone support; there are no observer-rated outcomes so
there is no need for blinding.
Clinical outcomes
Work and social adjustment scale (WSAS) [34,35]: this is
a 5-item self-report questionnaire that assesses impair-
ment of everyday functioning with scores of 0 to 40 (lower
scores denote less impairment). Each item asks the patient
to rate how much a particular area of their life is affected
by their problem (work, social activities, private leisure
activities, relationships) on a 9-point scale, where 0 repre-
sents ‘not at all’ and 8 represents ‘very severely’. This is a
brief and well-validated measure that has previously been
used in many studies and is part of routine data collection
in the NHS Improving Access to Psychological Therapies
(IAPT) Programme[36].
We chose a generic measure of functioning instead of
a symptom-specific measure for our primary outcome
for three reasons: a) improved functioning is a key ob-
jective of primary care mental health services with the
view of helping people return to work [37]; b) people
with depression and mixed anxiety are a heterogeneous
group and c) we can establish cost-effectiveness measur-
ing effects of functioning with both the WSAS, com-
monly used by clinicians, and the EQ-5D, commonly
used by health economists.
Beck depression inventory (BDI) [38]: this is a 21-item
questionnaire that measures presence and severity of de-
pression. Each item relates to a specific symptom of
depression and includes four statements corresponding
to scores 0, 1, 2 or 3 (higher scores, greater severity).
Patients choose one of the four statements to describe
the extent to which they were troubled by each symptom
over the previous week. The items are then summed to
Gega et al. Trials 2012, 13:151 Page 5 of 11
http://www.trialsjournal.com/content/13/1/151
obtain a total score that can range from 0 to 63 (higher
total scores indicate more severe depression). Standard
cut-offs are: 0 to 9, no depression; 10 to 18, mild-moderate
depression; 19 to 29, moderate-severe depression and 30 to
63, severe depression.
Beck anxiety inventory (BAI) [39]: this is a 21-item
self-report questionnaire that assesses the presence and
severity of anxiety. Each of its items corresponds to a
common symptom of anxiety, which patients rate based
on how much they were troubled by that symptom over
the previous week (0, not at all; 1,mildly troubled;
2,moderately troubled and 3, severely troubled). The
items are then summed to obtain a total score that can
range from 0 to 63 (higher scores, greater anxiety).
Common cut-off points are: 0 to 21, low anxiety; 22 to
35, moderate anxiety and over 36, severe anxiety.
Health-related quality of life - EQ-5D [40]: this is a
five-domain measure of health-related quality of life
covering mobility, self-care, usual activities, pain/dis-
comfort and anxiety/depression. Each domain has three
levels and patients tick the statement that best describes
their state of health at the time (no problems, 1; some/
moderate problems, 2 and severe/extreme problems, 3).
Responses to these five domains are converted into one
of 243 different health state descriptions, which range
between no problems in all five domains (11111) and se-
vere/extreme problems in all five domains (33333).
Patients also rate their overall impression of how good
or bad their health state is on the day of completion
using a separate scale of 0 to 100 (0 , worst imaginable
health state; 100, best imaginable health state). We have
selected the EQ-5D because it is commonly used to esti-
mate quality-adjusted life years (QALYs) for the eco-
nomic evaluation of health interventions [41] and allows
comparisons of the cost-effectiveness of different inter-
ventions across different conditions.
Patient health questionnaire (PHQ) - depression-9
item (PHQ-9) [42] and generalised anxiety disorder-7
item (GAD-7) [43]: the PHQ-9 and GAD-7 are brief
validated scales to screen for the presence and severity
of depression and generalised anxiety respectively, in
primary care. Each of the 9 items of PHQ-9 and of the
7 items of GAD-7 describes a common symptom of
depression or generalised anxiety respectively, which
patients rate on a scale of 0 to 3 according to how often
they have been troubled by this symptom in the previ-
ous 2 weeks (0, not at all; 1, for several days; 2, formore
than half the days; 3, nearly every day). Standard cut-
offs for PHQ-9 are 0 to 4, no depression; 5 to 9, mild
depression; 10 to 14, moderate depression; 15 to 19
moderately severe depression, 20 to 27 severe depres-
sion. For GAD-7 the cut-offs are 0 to 4, no anxiety; 5 to
10, mild anxiety; 11 to 15, moderate anxiety; 15 to 21,
severe anxiety.
The PHQ-9 and GAD-7 are subsidiary clinical out-
come measures collected by post at 12 and 24 weeks
post-randomization, and electronically every time
patients log into the cCBT system. We have included
them in the study because they are routinely used in the
NHS to screen for depression and anxiety in primary
care and to evaluate the effectiveness of psychological
therapies nationwide [36]. These will allow us to com-
pare our study findings with published national out-
comes on cCBT and related interventions [44,45]. We
will also test whether the PHQ-9 and GAD-7 can be as
sensitive as the BDI & BAI in measuring depression and
anxiety respectively but less cumbersome for patients to
complete.
Single-item anxiety and depression scores
The cCBT system asks patients to rate two questions at
the beginning of their session every time they log-into
the cCBT system (8 times). These are: ‘How anxious or
stressed have you felt in the past week?’ where 0 repre-
sents not at all and 8 represents extremely anxious),
and ‘How depressed have you felt in the past week?’
where 0 represents not at all and 8 represents extremely
depressed,.
Suicide
The cCBT system automatically asks questions about
the presence & frequency of suicide thoughts and about
suicide intent at the beginning of each session every
time patients log-into the cCBT system (8 times).
Patients answer the following questions: ‘Have you had
any thoughts about suicide in the last week?’ (yes/no).
If yes, ‘How often have you thought about ending your
life in the last week?’ (once, twice, three times, more
than three times), and ‘How seriously have you planned
to carry it out?’ (0, not very seriously; 8, very seriously).
Individual problem scores
The patient describes up to three problems during their
first cCBT session every time they log in to the cCBT
system at the beginning of their session (8 times) and
then they rate the level of distress that each problem
causes for them (0, no distress; 8, extreme distress).
Patient experiences
Computer-patient alliance scale (C-PAS) and therapist-
patient alliance scale (T-PAS)
These are two 15-item questionnaires that measure
patients’ experiences of using computerised self-help and
of having individualised support. Each item asks the pa-
tient to rate the statement that best describes their experi-
ence with either cCBT or with the support they received,
on a 9-point scale, where 0 represents ‘not at all’, and 8
represents ‘extremely’). The two scales are matched item-
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by-item to allow comparisons of the same therapeutic ele-
ments between using a computer vs. speaking to a person
(for example, ‘The therapist has contributed to improv-
ing my problems.’ vs. ‘The computer system has con-
tributed to improving my problems.’).
These are bespoke scales developed by the Chief In-
vestigator (LG) to assess therapy processes and patient
experiences in relation to this study. Existing standar-
dised measures, such as the Agnew relationship measure
[46] or the working alliance inventory [47], are designed
for conventional face-to-face psychotherapy and include
many items that are not relevant or did not address the
objectives of this study.
Patient experience interview (PEI)
The interview follows a structured guide with specific
questions and prompts under four headings: a) general
experiences and perspectives of treatment; b) hindering,
unhelpful, negative or disappointing aspects of treatment;
c) productive, helpful, positive or encouraging aspects of
treatment; d) suggestions and additional comments.
cCBT system usefulness, relevance and ease of use
The cCBT system automatically asks three questions at
the end of each cCBT session (8 times) about patient
experiences of using the system. These are; ‘Looking at
session x: How useful was it?’ (on a scale of 0 to 8,
where 0 represents not at all useful, and 8 represents very
useful); ‘Was it relevant to your problems? (on a scale of
0 to 8, where 0 represents not at all relevant, and 8
represents very relevant) and ‘How easy was it to follow?’
(on a scale of 0 to 8, where 0 represents very difficult,
and 8 represents very easy).
Resource use
Resource use questionnaire (RUQ)
The RUO is a standardised measure developed for this
project to estimate which resources and services patients
have been using in relation to their depression before,
during and after cCBT. The questionnaire has 10 sec-
tions that elicit information about patient contact with
healthcare professionals, use of other agencies and ser-
vices, medication and help from friends and family.
Therapist session records
Support staff maintain detailed electronic records of the
content of their sessions with individual patients and
their actual duration using a stop-watch; these are kept
in a password-protected web-based database at the
UEA. A random selection of the support sessions is
taped each time with the patient’s agreement. This is to
ensure session fidelity to the study protocol and to allow
for qualitative comparisons in the style and content of
support between the clinician and the assistant. The
support staff also keep written records of the duration
and content of their supervision sessions with the study’s
clinical supervisor (NR).
Sample size
Sample size calculations are based on a between-group
comparison of post-treatment scores at 12-weeks follow-
up post-randomisation on our primary outcome meas-
ure (WSAS), assuming a significance level of 0.05 with a
standard deviation of 8.5 for that measure; this standard
deviation was taken from Proudfoot et al. [6], whose
study used the same intervention, outcome measure and
follow-up interval.
A sample size of 35 per group (total 140 patients) is suf-
ficient to detect main effects (brief vs. extended, and
clinician vs. assistant) of 0.477 standard deviations (about
4.1 points) in our primary outcome measure with 80%
power, or of 0.522 (about 4.4 points) in our primary out-
come measures with 90% power. The estimated sample
size of 140 patients with available data can detect an inter-
action effect (for example, the difference between brief
and enhanced, compared between clinician and assistant)
of about 0.961 standard deviations (about 8.2 points) on
our primary outcome measure with 80% power.
Allowing for a 30% drop-out rate, we intend to ran-
domise 50 patients in each of the four groups (total 200
randomised patients). We estimate that about a third of
all screened patients may be unsuitable for the trial or
refuse participation (based on a similar pragmatic trial
by Marks et al. [48]), therefore to achieve 200 rando-
mised patients we aim to recruit a total of 300 referrals.
Our sample size calculation and effect estimates are
conservative. Our hope is that adjustment by the corre-
sponding baseline outcome measure reduces the stand-
ard error of the effect estimates and hence increases the
power for a given sample size.
Statistical analysis
Descriptive statistics will summarise demographic and
clinical features of those referred, those randomised,
those who complete the intervention (at least 5 cCBT
sessions) and those who complete at least one set of
post-baseline outcome measures. The same variables
and baseline values of the outcome measures will be
compared between brief and extended support, and be-
tween clinician and assistant at baseline. Where large
differences exist, these variables will be included as po-
tential confounders. Our primary analysis will be based
on the first batch of completed postal questionnaires
returned by the patients. These are posted out to the
patients at 12 weeks post-randomisation but the timing
of receiving completed questionnaires from the patients
is variable. The time of receipt is recorded and may be
included as a covariate.
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Linear models will be used to estimate the main effects
of the two treatments. An estimate and confidence inter-
val for the interaction term will be obtained. Corre-
sponding adjusted estimates will be obtained adjusting
for baseline only, and for baseline and the potential con-
founders identified at baseline. Effect sizes will be calcu-
lated using Cohen’s d [49]. The number of patients
showing clinically significant and reliable change [50]
will be reported where possible. C-PAS and T-PAS will
be compared for each group using mixed-effects models
and their similarity will be assessed using intra-class
correlation.
The primary analysis will include patients in the groups
to which they had been randomly assigned regardless of
the actual treatment they have received. The primary ana-
lysis will include non-missing data only, but the baseline
characteristics of missing and non-missing values will be
compared to assess the pattern of missing data. Further, as
recommended by Altman [51], sensitivity analyses will be
performed by employing multiple imputation techniques.
Where a few items within a scale are missing for an indi-
vidual participant we will impute using that person’s scale
average.
A per-protocol analysis will also be performed on the
main outcomes using completers only, which we define as
those patients who complete at least 5 cCBT sessions. We
will compare sub-group effects by including interaction
terms in appropriate linear models. We will use linear
models to investigate which demographic and clinical vari-
ables predict primary outcome, session completion and
patient satisfaction. Interaction terms may be included to
investigate which variables modify the main effects. Sec-
ondary analysis will be carried out using the electronic
data collected by the cCBT system in every session. The
series of session electronic outcomes will be summarised
and compared between treatment groups using repeated
measures analysis.
Qualitative analysis
Narrative data will be analysed using thematic and content
analysis. Thematic analysis will identify and describe fea-
tures within the textual data, whereas content analysis will
look for frequency of occurrence of these features. Quali-
tative analysis will include repeated readings of the text to
enable familiarisation with the data, noting preliminary
features and patterns of interest, coding the transcripts,
adding and modifying codes, and collating data relevant to
existing codes until no new codes emerge [52]. The fol-
lowing textual data will be analysed:
1. Patients’ narrative responses on the screening
questionnaire to provide an overview of commonly
presenting features of depression/anxiety in primary
care for patients seeking computerised therapy.
2. Clinical written records to identify staff rationale for
decision-making on suitability and prognosis based
on patients’ responses to a standardised
questionnaire and after a telephone assessment
interview.
3. Recorded sessions and written clinical records from
support staff to identify prominent features in the
content and delivery of different types of support.
4. Researcher records to identify reasons why patients
did not take up cCBT pre-randomisation or dropped
out post-randomisation.
5. Recorded exit interviews to identify aspects of cCBT
or the adjunct support that patients considered
relevant or helpful, or hindering or missing, and any
suggestions they may have to improve the study or
the intervention.
Economic evaluation
To establish the cost-effectiveness of clinicians vs. assis-
tants offering brief vs. extended support, we will com-
bine the effects and costs of each of the four support
modes (brief-clinician vs. brief-assistant vs. extended-
clinician vs. extended-assistant support). Effects will be
measured using both the WSAS and the EQ-5D. Cost
will be estimated by assigning appropriate unit costs to
resources used by patients (therapist contact time, cCBT
use, medication use, GP consultations, in-patient and
out-patient care, etcetera) before, during and after the
interventions. All costs will be calculated in UK £ Ster-
ling using both internal sources (for example, the rele-
vant local organisations’ finance departments) and
external sources (for example, Personal Social Services
Research Unit (PSSRU)-health and social care costs
[53]). We will estimate cost-effectiveness from the per-
spective of the NHS and social services according to
NICE guidelines [41]) and also from a broader societal
perspective (encompassing for example, patient travel
costs, lost productivity and other support received).
If one support mode is shown to be less costly and more
effective than all others, determining the most cost-
effective support mode will be straightforward, as that
support mode would dominate others. Alternatively, the
incremental cost per unit of effect will be estimated for
each support mode, and the resulting incremental cost-
effectiveness ratio (ICER) will be assessed in relation to a
range of cost-effectiveness thresholds. To characterise the
level of uncertainty in decision-making based on the cost-
effectiveness analysis, we will present economic data based
on the cost-effectiveness acceptability curve (CEAC) and
cost-effectiveness acceptability frontier (CEAF) [54].
Additionally, sub-group analysis (severe vs. mild/moder-
ate depression or anxiety; referrals from GPs vs. mental
health professionals) will be conducted in order to assess
how the costs and effects of different modes of support for
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cCBT vary across different patient groups. Sensitivity ana-
lysis will assess the robustness of conclusions to key
assumptions that are made within the economics analysis
(for example, the level of payment for clinicians or assis-
tants employed). Finally, we will estimate the budgetary im-
pact for the NHS of the population-wide long-term
implementation of the most cost-effective mode of indivi-
dualised support for cCBT.
Public & patient involvement
A focus group involving public and service user representa-
tives was set up with help from the Patient and Public In-
volvement in Research (PPIRes) at the local Primary Care
trust (NHS Norfolk), to discuss cCBT implementation and
patient recruitment. This focus group reviewed some of the
study documents (such as the patient information sheet,
screening questionnaire and invitation letter) and made
recommendations for their improvement and dissemin-
ation. Two of the focus group members have been partici-
pating in the study trial management group and steering
committee. The same members will be actively involved in
the interpretation and dissemination of the study’s findings.
Ethical issues
Approvals were granted by a regional NHS Research Eth-
ics Committee and the Research & Development (R&D)
departments of the relevant NHS Trusts. Patient consent
is obtained by post. Patients are advised to return the con-
sent form and self-referral questionnaire by post and not
by email, to protect confidentiality. Patients can withdraw
from the study at any point, without providing a reason,
but data collected up to their withdrawal will still be used.
Patients retain cCBT access for 24 weeks even if they
choose not to speak to the support staff. If a patient needs
further treatment upon completion of the study, research
staff can directly make a referral to the local psychological
therapies service or discuss treatment options with the
patient’s GP.
Patients’ research data are stored on a password-
protected laptop. Information recorded on the cCBT sys-
tem can only be accessed by the Chief Investigator, the
study’s research administrator and the individual mem-
ber of staff who offers support to each patient. The sup-
port staff do not have access to any named individual
feedback about experiences of therapy. Anonymised
electronic data (such as demographic information, clin-
ical outcome ratings, extracts from patient interviews
and therapist field notes) are accessible only by research
and clinical staff involved in the study. Digital recordings
are wiped once the transcribed data are stored safely and
all identifying information is omitted from transcripts.
Archive copies of postal questionnaires and transcripts
will be retained for 10 years and then disposed of in ac-
cordance with the University and NHS guidelines.
Discussion
Methodological considerations
The factorial design of our study increases its efficiency
by allowing the concurrent investigation of two different
types of support for cCBT, that is, how a clinician com-
pares to an assistant and how brief support compares to
extended support, with a single sample of participants.
For this, the proposed sample size of 200 randomised
patients, with the aim of retaining and analysing data
from 140 participants, will be adequate to detect a differ-
ence between brief and extended support (for both clin-
ician and assistant) and between clinician and assistant
(for both brief and extended support). We will estimate
the interaction effect between the two different types of
support, but the study is not powered to test it signifi-
cance unless it is very large.
Most factorial RCTs assume that there is no inter-
action between their two studied interventions and the
presence of strong interactions may lead to loss of power
for detecting the main effects of the interventions. This
study is not powered to detect an interaction between
our interventions, unless this interaction is very large.
Whilst a detectable interaction between the duration of
support and the person giving support will be interesting
from a clinical perspective and potentially informative
for health service delivery, it will affect the way we inter-
pret our main effects.
Practical considerations
Difficulties with patient recruitment and retention in
computer-based interventions are reflected in the low
take-up and high attrition rates reported in the literature
[13,17,55]. Moreover, this study includes people with de-
pression, a condition which by definition impairs motiv-
ation and may make it more difficult for patients to start
or continue with therapy. To maximise recruitment and
take-up rates, we have kept our exclusion criteria very
broad (patients could have any other concurrent treat-
ments and there was no upper cut-off for depression se-
verity). We have also introduced flexible ways of
receiving referrals into the study (by telephone, email,
text or post from various sources including GPs or any
other health professionals, and by public adverts).
To prevent drop-outs and maximise cCBT usage and
data completion, we have offered participants the option
of accessing cCBT at home or in public places (libraries,
cafes, etcetera.) and of having adjunct support or return-
ing their questionnaires and giving us feedback via email,
post or telephone. To date, all outcome measures have
been received by post, all participants accessed cCBT
from home and all support sessions took place by tele-
phone with the exception of appointments or cancella-
tions, which tend to happen via email or text.
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An important point of consideration for our study is that
there is no face-to-face contact with the researchers or the
clinicians at any point because all referrals, assessments,
interventions and data collection are completed remotely
via telephone, computer or post. This lowers the research
costs (for example, there is no need to rent rooms or to
travel to people’s homes, or to employ extra people to allow
for loss of time because of travelling) and reflects routine
conditions in the UK primary care psychological therapy
services, in which patient assessments and cCBT delivery
are completed mostly by telephone as part of so-called step
2 interventions.
We cannot tell whether the lack of face-to-face contact
may compromise take-up, completion or effectiveness of
cCBT or whether the addition of face-to-face contact could
have enhanced those. Face-to-face support has been shown
to have better outcomes than telephone support in self-
help for bulimia [23], and lack of face-to-face contact was
the reason given by a third of all drop-outs from an online
intervention for post-traumatic stress disorder [56]. On the
other hand, telephone-delivered CBT (as a stand-alone
intervention and not as support to a computer system) was
found to be as effective and acceptable as face-to-face CBT
for obsessive-compulsive disorder (OCD) [57] and for
chronic fatigue syndrome [58].
Potential implications
With depression being one of the most burdensome health
problems worldwide, there is an increasing interest in
technology-mediated interventions, such as cCBT, which
can be accessed relatively easily in the community by large
numbers of people. Literature suggests that personal sup-
port may be a necessary adjunct to cCBT to keep people
motivated or to improve outcomes, but we do not know
who should provide this support and for how long. The
results of this study could indicate whether patients benefit
more from extended vs. brief support or from support
offered by a clinician or an assistant. The study will also in-
dicate whether brief-assistant support may appear more
economical but may compromise outcomes and include
hidden costs, and whether the perceived more expensive
option of extended clinician support can be offset by better
clinical outcomes and greater patient satisfaction. Finally,
the study can lead to recommendations as to how tele-
phone support could be tailored to suit different patients
and which mix of staff expertise and support duration
could optimise clinical outcomes and patient satisfaction
with cCBT within the current budget constraints of health-
care providers.
Trial status
Patient recruitment was ongoing at the time of manu-
script submission and stopped in June 2012. Data collec-
tion will continue until September 2012.
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